Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1902002215
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
333 Cottman Ave
Philadelphia, PA, 19111
Phone (215) 728-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
659 services
Medicare patients, 2024
230
Average age 74
Drug cost, 2024
$4.3M
1,723 prescriptions
Company payments, 2025
$2,474
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew R Zibelman was code 99215 (office e&m - established), 269 times for 122 patients. In total Matthew R Zibelman billed 659 services in 10 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 269 | 122 | $108.38 | $29K |
| 99214 Office E&M - Established | Facility | 214 | 133 | $71.31 | $15K |
| 99214 Office E&M - Established | Office | 60 | 39 | $98.88 | $5,933 |
| 99205 Office E&M - New | Facility | 46 | 46 | $136.90 | $6,297 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 13 | $63.87 | $1,469 |
By year: 2022 $59K for 643 services; 2023 $63K for 670 services; 2024 $62K for 659 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew R Zibelman prescribed most often to Medicare patients was Prednisone, with 504 prescriptions and refills. In total Matthew R Zibelman wrote 1,723 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 504 | 561 | 86 | $1,850 |
| Abiraterone Acetate Generic | 415 | 422 | 69 | $472K |
| Orgovyx Relugolix | 128 | 132 | 23 | $346K |
| Xtandi Enzalutamide | 96 | 96 | 18 | $1.2M |
| Ondansetron Hcl Generic | 67 | 67 | 37 | $456 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 35 | 69 | Under 11 | $435 |
| Inlyta Axitinib | 31 | 31 | Under 11 | $548K |
| Zytiga Abiraterone Acetate | 28 | 36 | Under 11 | $254K |
| Dexamethasone Generic | 26 | 26 | 14 | $341 |
| Nubeqa Darolutamide | 24 | 24 | Under 11 | $270K |
| Olanzapine Generic | 24 | 24 | 12 | $477 |
| Erleada Apalutamide | 24 | 26 | Under 11 | $350K |
| Prochlorperazine Maleate Generic | 23 | 23 | 19 | $205 |
| Oxycodone Hcl Generic | 22 | 22 | 13 | $293 |
| Amlodipine Besylate Generic | 22 | 30 | Under 11 | $195 |
Brand drugs: 401 claims; generic drugs: 1,322 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew R Zibelman $2,474 ($2,474 in general payments such as food, travel and fees) from 11 companies. The largest payer was EMD Serono, Inc. with $1,900.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 1 | $1,900 |
| Exelixis Inc. EXEL | 2 | $309 |
| Pfizer Inc. PFE | 3 | $81.22 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $73.91 |
| Daiichi Sankyo Inc. 4568.T | 2 | $44.48 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $20.13 |
| Ferring Pharmaceuticals Inc. | 1 | $16.26 |
| Janssen Biotech, Inc. JNJ | 1 | $16.01 |
| Caris MPI, Inc. | 1 | $13.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.